ETF Managers Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | $36.2K | Buy |
+6,359
| New | +$36.2K | ﹤0.01% | 666 |
|
2021
Q2 | – | Sell |
-2,263
| Closed | -$168K | – | 706 |
|
2021
Q1 | $168K | Sell |
2,263
-13,323
| -85% | -$989K | ﹤0.01% | 619 |
|
2020
Q4 | $1.46M | Buy |
15,586
+5,367
| +53% | +$502K | 0.03% | 215 |
|
2020
Q3 | $403K | Sell |
10,219
-6,356
| -38% | -$251K | 0.01% | 356 |
|
2020
Q2 | $541K | Buy |
+16,575
| New | +$541K | 0.02% | 254 |
|